These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24890594)

  • 1. Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.
    Chopra T; Marchaim D; Johnson PC; Awali RA; Doshi H; Chalana I; Davis N; Zhao JJ; Pogue JM; Parmar S; Kaye KS
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4630-5. PubMed ID: 24890594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance.
    Fitzpatrick MA; Ozer E; Bolon MK; Hauser AR
    J Infect; 2015 Feb; 70(2):144-52. PubMed ID: 25246361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
    Esterly JS; Griffith M; Qi C; Malczynski M; Postelnick MJ; Scheetz MH
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4844-9. PubMed ID: 21825287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Mortality in Children with
    Choe YJ; Lee HJ; Choi EH
    Microb Drug Resist; 2019 Oct; 25(8):1210-1218. PubMed ID: 31120349
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case-control study.
    Gu Y; Jiang Y; Zhang W; Yu Y; He X; Tao J; Hou X; Wang H; Deng M; Zhou M; Xu J
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115229. PubMed ID: 33161239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure.
    Liou BH; Lee YT; Kuo SC; Liu PY; Fung CP
    Antimicrob Agents Chemother; 2015; 59(6):3637-40. PubMed ID: 25824230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
    Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
    J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of bacteremia caused by Acinetobacter species other than A. baumannii: comparison with A. baumannii bacteremia.
    Choi SH; Choo EJ; Kwak YG; Kim MY; Jun JB; Kim MN; Kim NJ; Jeong JY; Kim YS; Woo JH
    J Infect Chemother; 2006 Dec; 12(6):380-6. PubMed ID: 17235644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): report of 13 cases.
    Seifert H; Strate A; Schulze A; Pulverer G
    Clin Infect Dis; 1993 Oct; 17(4):632-6. PubMed ID: 8268343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.
    Chopra T; Marchaim D; Awali RA; Krishna A; Johnson P; Tansek R; Chaudary K; Lephart P; Slim J; Hothi J; Ahmed H; Pogue JM; Zhao JJ; Kaye KS
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6270-5. PubMed ID: 24100492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.
    Tacconelli E; Cataldo MA; De Pascale G; Manno D; Spanu T; Cambieri A; Antonelli M; Sanguinetti M; Fadda G; Cauda R
    J Antimicrob Chemother; 2008 Nov; 62(5):1130-7. PubMed ID: 18635519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia.
    Chang YY; Liu YM; Liu CP; Kuo SC; Chen TL;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):148-152. PubMed ID: 29050749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
    Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
    Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
    Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endemic carbapenem-nonsusceptible
    Saharman YR; Karuniawati A; Sedono R; Aditianingsih D; Sudarmono P; Goessens WHF; Klaassen CHW; Verbrugh HA; Severin JA
    Antimicrob Resist Infect Control; 2018; 7():5. PubMed ID: 29344351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia.
    Freire MP; de Oliveira Garcia D; Garcia CP; Campagnari Bueno MF; Camargo CH; Kono Magri ASG; Francisco GR; Reghini R; Vieira MF; Ibrahim KY; Rossi F; Hajjar L; Levin AS; Hoff PM; Pierrotti LC; Abdala E
    Clin Microbiol Infect; 2016 Apr; 22(4):352-358. PubMed ID: 26711434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acinetobacter calcoaceticus-baumannii complex bacteremia: analysis of 82 cases.
    Lin SY; Wong WW; Fung CP; Liu CE; Liu CY
    J Microbiol Immunol Infect; 1998 Jun; 31(2):119-24. PubMed ID: 10596990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors.
    Chiang MC; Kuo SC; Chen SJ; Yang SP; Lee YT; Chen TL; Fung CP
    Infection; 2012 Feb; 40(1):19-26. PubMed ID: 21887526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent bacteremia caused by the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Lai CC; Hsu HL; Tan CK; Tsai HY; Cheng A; Liu CY; Huang YT; Liao CH; Sheng WH; Hsueh PR
    J Clin Microbiol; 2012 Sep; 50(9):2982-6. PubMed ID: 22760035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.